NASDAQ:SGRY - Surgery Partners Stock Price, Forecast & News

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Surgery Partners Inc (NASDAQ:SGRY) posted its quarterly earnings data on Tuesday, November, 5th. The company reported ($0.28) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.34) by $0.06. The company had revenue of $452 million for the quarter, compared to analysts' expectations of $452.30 million. Surgery Partners had a negative net margin of 11.26% and a negative return on equity of 5.32%. Surgery Partners's revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.19) earnings per share. View Surgery Partners' Earnings History.

Surgery Partners is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Surgery Partners.

Surgery Partners will be holding an earnings conference call on Thursday, March 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

3 brokers have issued 1 year target prices for Surgery Partners' shares. Their forecasts range from $12.00 to $20.00. On average, they anticipate Surgery Partners' share price to reach $17.00 in the next twelve months. This suggests that the stock has a possible downside of 5.7%. View Analyst Price Targets for Surgery Partners.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Surgery Partners.

Media coverage about SGRY stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Surgery Partners earned a daily sentiment score of 1.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Surgery Partners.

Surgery Partners saw a drop in short interest in January. As of January 31st, there was short interest totalling 4,520,000 shares, a drop of 9.8% from the January 15th total of 5,010,000 shares. Based on an average daily volume of 366,200 shares, the short-interest ratio is presently 12.3 days. Approximately 21.9% of the company's stock are short sold. View Surgery Partners' Current Options Chain.

Some companies that are related to Surgery Partners include HCA Healthcare (HCA), Universal Health Services (UHS), Tenet Healthcare (THC), Community Health Systems (CYH) and Quorum Health (QHC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Verizon Communications (VZ), NVIDIA (NVDA), Advanced Micro Devices (AMD), Visa (V), Amarin (AMRN), Mazor Robotics (MZOR), Xilinx (XLNX), Enterprise Products Partners (EPD), Energy Transfer LP Unit (ET) and Select Medical (SEM).

Surgery Partners' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Royce & Associates LP (2.83%), Goldman Sachs Group Inc. (1.46%), Pictet Asset Management Ltd. (1.29%), State Street Corp (1.00%), Bank of America Corp DE (0.38%) and Marshall Wace LLP (0.37%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View Institutional Ownership Trends for Surgery Partners.

SGRY stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Schonfeld Strategic Advisors LLC, Strs Ohio, Royce & Associates LP, Dimension Capital Management LLC, Victory Capital Management Inc., Victory Capital Management Inc. and Credit Suisse AG. View Insider Buying and Selling for Surgery Partners.

SGRY stock was acquired by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP, Marshall Wace LLP, State Street Corp, Public Sector Pension Investment Board, Trexquant Investment LP, California Public Employees Retirement System, Los Angeles Capital Management & Equity Research Inc. and SlateStone Wealth LLC. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans and Teresa Deluca. View Insider Buying and Selling for Surgery Partners.

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SGRY stock can currently be purchased for approximately $18.03.

Surgery Partners has a market capitalization of $901.50 million and generates $1.77 billion in revenue each year. The company earns $-205,710,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Surgery Partners employs 11,000 workers across the globe.View Additional Information About Surgery Partners.

The official website for Surgery Partners is http://www.surgerypartners.com/.

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]